187 related articles for article (PubMed ID: 20655969)
1. Novel insights for the treatment of Alzheimer's disease.
Kurz A; Perneczky R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):373-9. PubMed ID: 20655969
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease: a general introduction and pathomechanism.
Finder VH
J Alzheimers Dis; 2010; 22 Suppl 3():5-19. PubMed ID: 20858960
[TBL] [Abstract][Full Text] [Related]
4. Current therapeutic strategy in Alzheimer's disease.
Singh S; Kushwah AS; Singh R; Farswan M; Kaur R
Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1651-64. PubMed ID: 23161037
[TBL] [Abstract][Full Text] [Related]
5. Drugs targeting Alzheimer's disease: some things old and some things new.
Michaelis ML
J Pharmacol Exp Ther; 2003 Mar; 304(3):897-904. PubMed ID: 12604663
[TBL] [Abstract][Full Text] [Related]
6. Silibinin: a novel inhibitor of Aβ aggregation.
Yin F; Liu J; Ji X; Wang Y; Zidichouski J; Zhang J
Neurochem Int; 2011 Feb; 58(3):399-403. PubMed ID: 21185897
[TBL] [Abstract][Full Text] [Related]
7. Beyond amyloid: the future of therapeutics for Alzheimer's disease.
Lane RF; Shineman DW; Steele JW; Lee LB; Fillit HM
Adv Pharmacol; 2012; 64():213-71. PubMed ID: 22840749
[TBL] [Abstract][Full Text] [Related]
8. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
Cacabelos R
Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics in Alzheimer's disease.
Cacabelos R
Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
[TBL] [Abstract][Full Text] [Related]
11. Disease-modifying therapies in Alzheimer's disease.
Salloway S; Mintzer J; Weiner MF; Cummings JL
Alzheimers Dement; 2008 Mar; 4(2):65-79. PubMed ID: 18631951
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease.
Han M; Liu Y; Tan Q; Zhang B; Wang W; Liu J; Zhang XJ; Wang YY; Zhang JM
Eur J Pharmacol; 2011 Apr; 657(1-3):104-10. PubMed ID: 21316359
[TBL] [Abstract][Full Text] [Related]
13. beta-Secretase, APP and Abeta in Alzheimer's disease.
Vassar R
Subcell Biochem; 2005; 38():79-103. PubMed ID: 15709474
[TBL] [Abstract][Full Text] [Related]
14. Secretases as therapeutic targets for Alzheimer's disease.
Woo HN; Baik SH; Park JS; Gwon AR; Yang S; Yun YK; Jo DG
Biochem Biophys Res Commun; 2011 Jan; 404(1):10-5. PubMed ID: 21130746
[TBL] [Abstract][Full Text] [Related]
15. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.
Frisardi V; Solfrizzi V; Seripa D; Capurso C; Santamato A; Sancarlo D; Vendemiale G; Pilotto A; Panza F
Ageing Res Rev; 2010 Oct; 9(4):399-417. PubMed ID: 20444434
[TBL] [Abstract][Full Text] [Related]
16. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].
Kuzuhara S
Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870
[TBL] [Abstract][Full Text] [Related]
17. Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease.
Haas C
J Alzheimers Dis; 2012; 28(2):241-81. PubMed ID: 21987594
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease: beta-Amyloid protein and tau.
Morishima-Kawashima M; Ihara Y
J Neurosci Res; 2002 Nov; 70(3):392-401. PubMed ID: 12391602
[TBL] [Abstract][Full Text] [Related]
19. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
Song MS; Rauw G; Baker GB; Kar S
Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
[TBL] [Abstract][Full Text] [Related]
20. Amyloid clearance as a treatment target against Alzheimer's disease.
Kurz A; Perneczky R
J Alzheimers Dis; 2011; 24 Suppl 2():61-73. PubMed ID: 21422524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
